Health Catalyst Inc (NASDAQ: HCAT) open the trading on Wednesday, with a bit cautious approach as it glided -0.25% to $4.03, before settling in for the price of $4.04 at the close. Taking a more long-term approach, HCAT posted a 52-week range of $3.49-$9.24.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 38.24% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 38.24%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -13.63%. This publicly-traded company’s shares outstanding now amounts to $69.48 million, simultaneously with a float of $66.23 million. The organization now has a market capitalization sitting at $280.49 million. At the time of writing, stock’s 50-day Moving Average stood at $3.94, while the 200-day Moving Average is $5.81.
Health Catalyst Inc (HCAT) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Health Information Services industry. Health Catalyst Inc’s current insider ownership accounts for 4.84%, in contrast to 79.76% institutional ownership. According to the most recent insider trade that took place on Jun 05 ’25, this organization’s General Counsel sold 6,057 shares at the rate of 3.94, making the entire transaction reach 23,891 in total value, affecting insider ownership by 151,125.
Health Catalyst Inc (HCAT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.08 per share during the current fiscal year.
Health Catalyst Inc’s EPS decrease for this current 12-month fiscal period is -13.63% and is forecasted to reach 0.38 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 31.21% through the next 5 years, which can be compared against the 38.24% growth it accomplished over the previous five years trading on the market.
Health Catalyst Inc (NASDAQ: HCAT) Trading Performance Indicators
Let’s observe the current performance indicators for Health Catalyst Inc (HCAT). It’s Quick Ratio in the last reported quarter now stands at 1.24. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.90.
In the same vein, HCAT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.15, a figure that is expected to reach 0.03 in the next quarter, and analysts are predicting that it will be 0.38 at the market close of one year from today.
Technical Analysis of Health Catalyst Inc (HCAT)
[Health Catalyst Inc, HCAT] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 74.79% While, its Average True Range was 58.97%.
Raw Stochastic average of Health Catalyst Inc (HCAT) in the period of the previous 100 days is set at 24.63%, which indicates a major fall in contrast to 83.76% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.21 that was lower than 0.28 volatility it exhibited in the past 100-days period.
